What It Targets Our GHK-Cu topical peptide is designed to target: Fine lines (crows feet, smile lines) and early wrinkles needing gentle, consistent softening. Mild to moderate laxity, crepiness, and loss of firmness in the face, neck, or dcollet. Photodamagedull tone, uneven texture, mottled pigmentation, and residual sun spots. Posttreatment skin (microneedling, peels, laser) that needs accelerated repair and reduced downtime. Benefits Topical GHK-Cu is believed to help with: Collagen + elastin boost: GHKCu cream has been shown to increase collagen I and III, dermal thickness, and elasticity, with clinical trials reporting up to ~3055% reductions in wrinkle volume and meaningful improvements versus retinoic acid or vitamin C in some studies. Barrier repair and calming: Copper peptides help restore barrier proteins and lipids, reducing redness, irritation, and dehydration while protecting skin from oxidative and inflammatory damage. Texture and tone refinement: Regular use smooths rough patches, softens acne marks, and helps lighten mottled hyperpigmentation and sun damage for a more even, luminous tone. Postprocedure friendly: Compared with many acids or strong retinoids, GHKCu is better tolerated and frequently used to speed healing and results after microneedling, laser, and RF, making it a perfect Better Med Spa addon.
EVERY batch: independently tested Active ingredient content guaranteed 100% free from artificial colors/flavors, titanium dioxide, GMOs, nanoparticles, magnesium stearate In-house production in Salzburg (BIOGENA Good Health World) Premium raw materials sourced directly from global market leaders What sets us apart For us, knowledge is more than just information its inspiration
How should I order sterile, singleuse intramuscular needles for a patient receiving vitamin B12 injections?
In addition, the molecular perturbations induced in HPV-16 E7 Mut did not interfere with the ability of the oncoprotein to bind in vitro to the oncosuppressor protein pRb, a molecular target of E7 (Figure 4C)
This nitric-oxide-dopamine axis positions BPC-157 within a pharmacological space that extends well beyond tissue repair, into neuromodulation research
